The authors describe an improved method for the prevention of ocular diseases in children, consisting in formation of risk groups starting from female consulting centers ("provisional" group), then at maternity hospitals ("provisional" and "reliable" groups), and then at the outpatient clinic after examination by an ophthalmologist ("actual" and "reliable" groups). This work does not require extra staff or finances, and it helps reduce the incidence of ocular diseases, poor vision, and blindness almost twofold.

Download full-text PDF

Source

Publication Analysis

Top Keywords

ocular diseases
8
"reliable" groups
8
[improvement method
4
method prehospital
4
prehospital protection
4
protection vision]
4
vision] authors
4
authors describe
4
describe improved
4
improved method
4

Similar Publications

Integrated analysis of genetic, proteinic, and metabolomic alterations in Behcet's disease.

Sci Rep

January 2025

Department of Ophthalmology, Bishan hospital of Chongqing medical university, Bishan Hospital of Chongqing, Chongqing, China, 402760.

Numerous studies have investigated the alterations of genes, proteins, and metabolites in Behcet's disease (BD). By far, little is known about the depiction of panoramic changes underlying this disease. This study purposed to assess the consistently dysregulated genes, proteins, and metabolites in BD across publications using the vote-counting approach.

View Article and Find Full Text PDF

Purpose: To develop an artificial intelligence algorithm to automatically identify the anterior segment structures and assess multiple parameters of primary angle closure disease (PACD) in ultrasound biomicroscopy (UBM) images.

Design: Development and validation of an artificial intelligence algorithm for UBM images.

Methods: 2339 UBM images from 592 subjects were collected for algorithm development.

View Article and Find Full Text PDF

Pharmaceutical excipients, commonly known as inactive ingredients, encompass any substance aside from the active ingredient that fulfills a distinct and vital role in a formulation. Their purpose is to enhance specific characteristics, whether associated with the performance of the formulation or aspects related to patient comfort, safety, and acceptability. Because of the limited toxicity studies provided, and the several allergic and toxic side effects that have been reported throughout the years, it is not trivial for the regulatory agencies to approve inactive ingredients for human use.

View Article and Find Full Text PDF

Fluorinated multifunctional polymer vesicles for enhanced ocular surface penetration and synergistic treatment of dry eye disease.

J Control Release

January 2025

National Engineering Research Center of Ophthalmology and Optometry, School of Biomedical Engineering, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China. Electronic address:

Current pharmacotherapy for DED is limited by a vicious inflammatory cycle in which reactive oxygen species (ROS) play a critical role. Additionally, topical eye drop therapy for DED often suffers from poor ocular availability due to multiple ocular surface barriers. Considering the key role of the ROS-NLRP3-IL-1β signaling axis in DED, in this investigation, fluorinated multifunctional polymer vesicles were developed for enhanced ocular surface penetration and synergistic DED therapy by combining ROS scavenging and immunomodulation.

View Article and Find Full Text PDF

Purpose: The study aims to compare dry eye disease (DED) prevalence and severity between seropositive and seronegative Sjögren disease (SjD).

Methods: Prospective, consecutive, comparative cross-sectional cohort study. A total of 160 eyes of 80 patients with SjD by The American College of Rheumatology and the European League Against Rheumatism 2016 criteria were included: 55 seropositive and 25 seronegative SjD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!